The empathetic audio companion for people impacted by cancer.Elly is a leading empathetic audio companion for people impacted by cancer. The app helps patients improve their quality of life and emotional well-being through Elly’s friendly voice. She is a persona who comforts, supports and motivates patients to live healthier and happier. Elly is recommended by leading hospitals, oncologists and allied health professionals, who have limited face-time with patients to provide support, education and motivation. Each day, patients listen to a 90 second Daily Summary of audio content through the Elly smartphone app. Elly references a motivational story, she discusses an oncology topic, and leaves patients with an inspirational message. She also provides content around motivation, u... [Read More]
Min Investment
$1,000Amount Raised
$483,134Goal
$500K-$1MDays Left
0Los Angeles, CA
CrowdLustro Research Report
Elly
Industry:
Healthcare
Security Type:
Convertible Note
A convertible security is a security that can be converted into another security, typically equity in the next round of financing.
Debt and Equity Opportunity
Date Filed:
October 02, 2020
Date Expires:
November 27, 2020
Open to Investors
Valuation Cap:
$5M
Platform:
SeedInvest
Use of Proceeds
- Product
- Content
- Research
- Marketing
- Growth
Management
Nikhil Pooviah
Co-founder
Previously co-founded one of the world's top cancer apps, CancerAid; Radiation Oncology Physician; Pitched and received deal on Shark Tank.
Simon Holland
Co-founder
Co-founded multiple tech startups including Australia's leading patient engagement platform with millions of patients.
Deal Structure
Round type: Pre-Seed
Conversion Discount: 20.0%
Interest Rate: 4.0%
Note Term: 12 months
Deal Perks
- Free lifetime access to any family or friends interested in using the Elly product
- Above + Branded Elly merchandise.
- Above + one-on-one calls with the co-founders.
Additional Reports
There are no additional research reports currently.
Key Deal Facts
- Establishing research collaborations with Ochsner, Duke, and Cedars-Sinai to conduct implementations and clinical studies in 2020
- Notable investors include Google, JumpStart Foundry, StartUp Health and Nex Cubed
- In a company conducted clinical study of 100 patients, users reported a 10% improvement in Quality of Life score
- Achieved an 88% user retention rate after 1 month during a company conducted study with 106 users, which is nearly 6x higher than average health app retention rate (15%)
- Experienced founders who have previously co-founded companies such as CancerAid, HotDoc, Vivi, and Papercloud
0 Comments